Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 3/20 | 0.62 |
| ▸ | ACHE | P22303 | 10/20 | 0.52 |
| ▸ | CASP2 | P42575 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | CNR1 | P21554 | 1/20 | 0.45 |
| ▸ | FAAH | O00519 | 1/20 | 0.44 |
| ▸ | NAAA | Q02083 | 1/20 | 0.44 |
| ▸ | BCHE | P06276 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17850602 | 0.92 | EPHX1 (0.75) | EPHX1CASP2MEN1KMT2AFAAH | |
| SCHEMBL18117414 | 0.88 | EPHX1 (0.50) | EPHX1ACHECASP2MEN1KMT2A | |
| SCHEMBL514302 | 0.85 | — | — | |
| Ammonia Solution, Strong SCHEMBL28983308 | 0.83 | EPHX1 (0.79) | EPHX1ACHEBCHE | |
| SCHEMBL11537151 | 0.79 | PAOX (0.50) | EPHX1ACHECASP2MEN1KMT2A | |
| SCHEMBL21732752 | 0.79 | EPHX1 (0.61) | EPHX1CASP2MEN1KMT2ACNR1 | |
| SCHEMBL443246 | 0.79 | EPHX1 (0.95) | EPHX1ACHECASP2 | |
| SCHEMBL17850583 | 0.79 | EPHX1 (0.43) | EPHX1KMT2AFAAH | |
| Carbamic Acid SCHEMBL27650019 | 0.78 | EPHX1 (0.70) | EPHX1ACHEBCHE | |
| SCHEMBL19725138 | 0.78 | CASP2 (0.48) | EPHX1ACHECASP2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2714036-B1 | SUBSITUTED ALIPHANES, CYCLOPHANES, HETERAPHANES, HETEROPHANES, HETERO-HETERAPHANES AND METALLOCENES USEFUL FOR TREATING HCV INFECTIONS | ACHILLION PHARMACEUTICALS INC (US) | 2016-06-22 | — | — | EP | disclosed |